NORFOLK, VA – August 19, 2010 – Genomind, LLC joined the Personalized Medicine Coalition (PMC), an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, representing more than 170 pharmaceutical, biotechnology, diagnostics, and information technology companies, as well as major academic centers and governmental agencies.
About the Personalized Medicine Coalition
The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. For more information on the Personalized Medicine Coalition, please visit www.PersonalizedMedicineCoalition.org.
About Genomind, LLC
Genomind, LLC is a company specializing in neuropsychiatric personalized medicine and was formed to facilitate the adoption of Personalized Medicine into psychiatry by assisting physicians in the selection of appropriate medicine based on genetic information. Genomind was founded by Ronald I. Dozoretz, MD, in 2009, and the company is advised by a group of renowned experts in the fields of human genetics and neuropsychiatric medicine. More information is available on Genomind’s website.